225 related articles for article (PubMed ID: 35218075)
1. TP53 mutations in head and neck cancer.
Nathan CA; Khandelwal AR; Wolf GT; Rodrigo JP; Mäkitie AA; Saba NF; Forastiere AA; Bradford CR; Ferlito A
Mol Carcinog; 2022 Apr; 61(4):385-391. PubMed ID: 35218075
[TBL] [Abstract][Full Text] [Related]
2. TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
Zhou G; Liu Z; Myers JN
J Cell Biochem; 2016 Dec; 117(12):2682-2692. PubMed ID: 27166782
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.
van Harten AM; Poell JB; Buijze M; Brink A; Wells SI; René Leemans C; Wolthuis RMF; Brakenhoff RH
Oral Oncol; 2019 Nov; 98():53-61. PubMed ID: 31541927
[TBL] [Abstract][Full Text] [Related]
4. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population.
Maruyama H; Yasui T; Ishikawa-Fujiwara T; Morii E; Yamamoto Y; Yoshii T; Takenaka Y; Nakahara S; Todo T; Hongyo T; Inohara H
Cancer Sci; 2014 Apr; 105(4):409-17. PubMed ID: 24521534
[TBL] [Abstract][Full Text] [Related]
6. Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer.
Deneka AY; Baca Y; Serebriiskii IG; Nicolas E; Parker MI; Nguyen TT; Xiu J; Korn WM; Demeure MJ; Wise-Draper T; Sukari A; Burtness B; Golemis EA
Clin Cancer Res; 2022 May; 28(9):1925-1937. PubMed ID: 35491653
[TBL] [Abstract][Full Text] [Related]
7. Distinct effects of alcohol consumption and smoking on genetic alterations in head and neck carcinoma.
Urashima M; Hama T; Suda T; Suzuki Y; Ikegami M; Sakanashi C; Akutsu T; Amagaya S; Horiuchi K; Imai Y; Mezawa H; Noya M; Nakashima A; Mafune A; Kato T; Kojima H
PLoS One; 2013; 8(11):e80828. PubMed ID: 24278325
[TBL] [Abstract][Full Text] [Related]
8. The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.
Martin D; Abba MC; Molinolo AA; Vitale-Cross L; Wang Z; Zaida M; Delic NC; Samuels Y; Lyons JG; Gutkind JS
Oncotarget; 2014 Oct; 5(19):8906-23. PubMed ID: 25275298
[TBL] [Abstract][Full Text] [Related]
9. Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer.
Caponio VCA; Troiano G; Adipietro I; Zhurakivska K; Arena C; Mangieri D; Mascitti M; Cirillo N; Lo Muzio L
Br J Cancer; 2020 Oct; 123(8):1302-1314. PubMed ID: 32684626
[TBL] [Abstract][Full Text] [Related]
10. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
11. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
12.
Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
[TBL] [Abstract][Full Text] [Related]
14. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
15. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
[TBL] [Abstract][Full Text] [Related]
16. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours.
Ragin CC; Taioli E; Weissfeld JL; White JS; Rossie KM; Modugno F; Gollin SM
Br J Cancer; 2006 Nov; 95(10):1432-8. PubMed ID: 17003776
[TBL] [Abstract][Full Text] [Related]
17. FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner.
Pifer PM; Yang L; Kumar M; Xie T; Frederick M; Hefner A; Beadle B; Molkentine D; Molkentine J; Dhawan A; Abdelhakiem M; Osman AA; Leibowitz BJ; Myers JN; Pickering CR; Sandulache VC; Heymach J; Skinner HD
Clin Cancer Res; 2024 Jan; 30(1):187-197. PubMed ID: 37819945
[TBL] [Abstract][Full Text] [Related]
18. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].
Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570
[TBL] [Abstract][Full Text] [Related]
19. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.
Sano D; Xie TX; Ow TJ; Zhao M; Pickering CR; Zhou G; Sandulache VC; Wheeler DA; Gibbs RA; Caulin C; Myers JN
Clin Cancer Res; 2011 Nov; 17(21):6658-70. PubMed ID: 21903770
[TBL] [Abstract][Full Text] [Related]
20. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C
Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
